ONYX BIOTEC LIMITED Share Price

₹ 39.10

+₹1.65 (4.41%)
1D
Last updated 13 Nov, 2026, 13:55 IST
NSE: ONYX
|
Pharmaceuticals

ONYX BIOTEC LIMITED Share Price Today

As of 15 Nov 2026, ONYX BIOTEC LIMITED share price is ₹39.10. The stock opened at ₹39.20, compared to its previous close of ₹37.45. During today's trading session, ONYX BIOTEC LIMITED share price moved in the range of ₹39.10 to ₹39.20, with an average price of ₹39.15 for the day. Looking at its last 52-week, the stock has touched a low of ₹24.20 and a high of ₹49.65. On the performance front, ONYX BIOTEC LIMITED share price has increased by 18.48% over the last six months and is down 8.96% on a year-on-year basis.

Share price over the last 1 day rose from 37.45 to 39.10, ranging between 37.45 and 39.20.
₹39.10
4.41% up today
₹39.20
1D LOW
1D HIGH

ONYX BIOTEC LIMITED Stock Insights

Stock Performance
OutperformingBeat Nifty by 15.87 % in last 6 month
Shareholding Pattern
PromoterPromoter decreased stake by 35.87%
Shareholding Pattern
FIIFII decreased stake by 79.38%
ONYX BIOTEC LIMITED stock performance
Open₹39.20
High₹39.20
Low₹39.10
Prev. close₹37.45
ONYX BIOTEC LIMITED trading activity
Volume6,000
Average traded price₹39.16
Last traded time01:55:18 13 Nov
Last traded quantity2,000
Circuit
L
H
₹37.15
₹41.05
52-week
L
H
₹24.20
₹49.65
Mkt Cap Cr
70.90
P/E
-325.83
P/B
1.28
ROA
-0.3%
ROE
-0.39%
ROCE
1.12%
Quick Ratio
1.14
EV/EBITDA
18.9

Based on fundamentals, this stock's

Performance: 3 out of 5, Neutral
Performance
Neutral
Onyx Biotec performance is moderate compared to markets
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Onyx Biotec appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,51,290.9141.085.059.61%13.79%18.65%2.3123.67
Divis Laboratories3,05,014.1190.716.9515.31%18.69%23.83%3.560.87
Torrent Pharmaceuticals1,77,333.2084.499.654.7%11.42%11.37%0.7533.99
Laurus Labs1,30,755.5698.1321.5711.58%22.11%20.91%0.6855.18
Zydus Lifesciences1,18,802.7127.614.277.63%15.1%14.86%0.9116.1
Dr. Reddy's Laboratories1,15,016.8941.682.964.79%7.21%8.58%1.3519.53
Cipla1,12,538.8139.443.186.6%8.18%10.8%2.521.48
Mankind Pharma1,09,622.1748.436.237.82%12.76%14.68%0.7426.42
Aurobindo Pharma1,05,236.6226.42.676.46%10.13%12.76%1.1512.54
Lupin90,544.0117.343.7613.08%21.65%24.54%1.4210.15

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

ONYX BIOTEC LIMITED Company Background

ISIN
INE0WVU01018
Sector Market Cap
₹ 70.90 Cr

Onyx Biotec Ltd. is a pharmaceutical company engaged in the manufacture, sale, and distribution of generic and proprietary pharmaceutical products. It develops, manufactures and distributes generic and branded pharmaceutical products in various forms, like water for injection (WFI), dry powder injections, and dry powder syrup. WFI is a sterile preparation of water, which is supplied only in single-dose containers, indicated only for diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection. Its dry powder injections include Ceftriaxone and Sulbactam for Injection, Cefazoline Sodium for Injection, and Cefepime and Tazobactam for Injection, among others. Its dry powder syrups include Cefpodoxime Proxetil, Cefuroxime Axetil, and others. Its core business is focused on providing end-to-end product development and manufacturing solutions to its clients. Its services also include preparation and filing of regulatory dossiers in the Indian and global markets.

ONYX BIOTEC LIMITED Financial Highlights

  • Revenue: ONYX BIOTEC LIMITED reported revenue of ₹69.91 crore in FY26 vs ₹63.12 crore in FY25. It showed an increase of 10.76% on a yearly basis.
  • Operating Profit: ONYX BIOTEC LIMITED reported an operating loss of ₹0.42 crore in FY26 vs ₹6.48 crore in FY25. It showed a decrease of 106.48% on a year-on-year basis.
  • Net Profit: ONYX BIOTEC LIMITED reported a net loss of ₹0.21 crore in FY26 vs ₹4.95 crore in FY25. It showed a decrease of 104.24% on a yearly basis.
Promoters
41.74%
FII
0.22%
Other DII
2.39%
Retail and other
55.64%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Mar 20255.36%
Sep 20251.95%
Mar 20261.07%
Sep 20260.22%

ONYX BIOTEC LIMITED Investment Returns

1 day
+4.41%
1 week
+13.01%
1 month
+5.68%
1 year
-8.96%
3 years
-31.10%
5 years
-31.10%

ONYX BIOTEC LIMITED Share Price History

ONYX BIOTEC LIMITED share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
13 Nov 26
₹39.20 / ₹39.10
+4.41%
12 Nov 26
₹37.45 / ₹37.45
+4.90%
11 Nov 26
₹35.50 / ₹35.70
+5.00%
08 Nov 26
₹36.30 / ₹34.00
-1.73%
Show more

ONYX BIOTEC LIMITED Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹69.47₹61.95₹53.75₹39.49
Other Income₹0.44₹1.17₹0.13₹0.12
Total Revenue₹69.91₹63.12₹53.87₹39.62
Total Expenses₹70.34₹56.64₹49.38₹37.07
Profit Before Tax-₹0.42₹6.48₹4.49₹2.55
Tax-₹0.21₹1.52₹0.86₹0.70
Profit After Tax-₹0.21₹4.95₹3.63₹1.84
EPS - Basic-₹0.12₹3.31₹3.05₹1.56
EPS - Diluted-₹0.12₹3.31₹3.05₹1.56

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹0.42₹6.48₹4.49₹2.55
Income before WC changes₹3.44₹11.08₹8.55₹0.36
Change in Assets-₹6.55-₹12.54-₹12.98-₹0.65
Change in Liabilities₹1.61₹2.88₹5.95₹2.24
Change in WC-₹4.93-₹9.66-₹7.03₹1.60
Cash flow from Operations-₹1.49₹1.42₹1.52₹1.96
Cash flow from Investing-₹4.58₹0.66-₹3.15-₹22.67
Cash flow from Financing₹1.50₹5.07₹3.09₹16.43
Total Cash Flow-₹4.57₹7.15₹1.46-₹4.29
Cash (Start of the year)₹8.61₹1.47₹0.01₹0.01
Cash (End of the year)₹4.04₹8.61₹1.47-₹4.28

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹43.88₹42.06₹44.58₹44.16
Current Assets₹51.28₹49.19₹29.56₹14.56
Total Assets₹95.15₹91.25₹74.14₹58.72
Current Liabilities₹32.53₹25.73₹22.55₹20.21
Net Current Asset₹18.75₹23.46₹7.01-₹5.64
Non-Current Liabilities₹7.22₹9.90₹26.30₹20.31
Equity Capital₹55.41₹55.62₹25.29₹18.20
Total Equity & Liabilities₹95.15₹91.25₹74.14₹58.72
* All values are in INR Crore
ONYX BIOTEC LIMITED market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
ONYX BIOTEC LIMITED technical summary
Bearish indicators4
Neutral indicators3
Bullish indicators1
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
59.11
Neutral
ATR (14)
1.3
Neutral
STOCH(9,6)
98.08
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
28.25
Bearish
UO(9)
45.34
Neutral
ROC(12)
4.97
Bullish
WillR(14)
-1.92
Bearish
Period
Simple value
Exponential vaue
5D
36.17
37.01
10D
36.06
36.56
20D
36.7
36.74
50D
38.19
37.78
100D
39.39
37.88
Volume trend — traded volume by day
13 Nov0L
12 Nov0L
11 Nov0L
8 Nov0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

ONYX BIOTEC LIMITED
Pharmaceuticals
Add Stock
Add Another

ONYX BIOTEC LIMITED Returns Calculator

Top Gainers

POWERINDIA Share Price
₹31595.00
+3050 (+10.68%)
AMBER Share Price
₹6772.00
+563 (+9.07%)
ANURAS Share Price
₹1300.60
+98.8 (+8.22%)
ITI Share Price
₹268.07
+17.06 (+6.8%)
ACI Share Price
₹455.05
+28.35 (+6.64%)
See more

Top Losers

ASTRAZEN Share Price
₹6031.50
-407 (-6.32%)
MAHSEAMLES Share Price
₹540.90
-29.7 (-5.21%)
FDC Share Price
₹371.45
-18.95 (-4.85%)
MANYAVAR Share Price
₹473.85
-23.3 (-4.69%)
NETWORK18 Share Price
₹26.95
-1.3 (-4.6%)
See more

ONYX BIOTEC LIMITED Share Price FAQs

Please be aware that ONYX BIOTEC LIMITED stock prices are subject to continuous fluctuations due to various factors.